skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
Jan 2, 2020 2020 FC 1 Seedlings Life Sciences v Pfizer We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...

Patents

Oct 29, 2019 2019 FC 1355 Janssen Inc. et al v Apotex Inc. We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” applica...

Patents

Feb 8, 2018 2018 FCA 33 Teva Canada Limited v. Janssen Inc. We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...

Patents

Feb 6, 2018 2018 FCA 32 Apotex Inc. v. Bayer Inc. We successfully represented Bayer Inc. on this appeal, which upheld the patentee’s right to elect its damages.

Patents

Dec 9, 2016 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al. We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...

Patents

Sep 9, 2016 2016 FC 1013 Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company We successfully represented Bayer in this patent infringement action. Following a six week trial, the Federal Court agreed that Bayer’s paten...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy